OncoRevive

Technology

 

Nanotechnology is science of small materials, when the size of particle is 100-1000 times smaller than the thickness of human hair! When nanotechnology meets other fields such as biology (i.e., which is the science related to cancer research), the impossible becomes possible!

At OncoRevive, we leverage our expertise in nanotechnology and address one of the most important needs of cancer research: Early Detection of Cancer!

Accurate

> 1 X
More reliable results

Fast

> 1 X
OncoRevive process is < 2h

Comprehensive

> 1 X
With detection of 30 biomarkers in single test

Affordable

> 1 %
Scalable technique
INNOVATIVE NANOTECHNOLOGY TRANSFORMS CANCER RESEARCH WITH A FOCUS ON EARLY DETECTION OF CANCER.

OncoRevive’s Technology

Liquid Biopsy

Non-Invasive: Analyzing body fluids like blood instead of using painful, invasive tissue biopsies.

Comprehensive: Providing a holistic view of the tumor environment, enhancing diagnostic accuracy.

Unmatched Sensitivity

High Efficiency: Capable of detecting single circulating tumor cells and other biomarkers in minimal sample volumes.

Comparative Advantage: Detecting critical biomarkers from different categories while other technologies could detect only one category of biomarkers.

Advancing Cancer Diagnosis

Multi-Omic Analysis:Identifying up to 30 different cancer biomarkers across proteomics, genomics, and glycomics.

Tailored Treatment:Enabling personalized treatment planning based on comprehensive biomarker analysis.

Quick Results:Delivering diagnostic results in less than 2 h.

User-Friendly: Designed for ease of use by pathology lab technicians without specialized training.

Affordability: 40% cheaper than competing technologies.

Lower Capital Costs:Requiring 20 times less capital cost, making it accessible for more pathology labs and hospitals.

Drop us a line!

We love our customers, so feel free to visit during normal business hours.

    OncoRevive

    Subscribe

    Get all our information in your inbox

    Solid biopsy (i.e., simply taking out a piece of tumor) is invasive approach that not only provides information about a piece of tumor owing to heterogeneous nature of tumor but also it is painful.
    OncoRevive’s technology is a liquid biopsy technique which capture circulating object and detect up to 30 different cancer biomarkers (proteins, genes, glycans). Such an analysis from different perspectives (proteomics, genomics, and glycomics) enables providing comprehensive information about cancer.
    Innovative Nanotechnology for Cancer Detection Transforms cancer research with a focus on early detection.

    OncoRevive’s Technology

    The results of analysis could be ready in less than 2h. The procedure is designed in a way that even a pathology lab technician could follow the procedure, leading to very fast but accurate analysis.
    Our uniquely designed nanoparticles could capture circulating objects in the blood (i.e., in the form of circulating tumor cells, circulating DNA, extracellular vesicles, exosomes, lipid nanoparticles, etc.) with high efficiency.
    Our technology is 40% more affordable for patients compared to other liquid biopsy techniques. In addition, our technology needs 20X less capital cost investment, enabling pathology labs and hospitals to easily join to the network of OncoRevive’s family.